Intellectual Property

  • February 09, 2026

    Fed. Circ. Sends Blood Pump Patent Fight Back To Mass.

    The Federal Circuit on Monday reversed a lower court's ruling that Abiomed Inc. hasn't infringed five patents on blood pump systems and methods, while backing the part of the decision that cleared the medical device technology company of allegations it infringed a different patent.

  • February 09, 2026

    'Baby Shark' Ruling Doesn't Stop Google Anti-Phishing Fight

    A Manhattan federal judge granted injunctive relief Monday to Google in its effort to combat an alleged China-based phishing enterprise, holding that faraway defendants were properly served electronically despite an appellate ruling mandating mail service in a "Baby Shark" infringement case.

  • February 09, 2026

    Novo Nordisk Sues Hims & Hers Over Knockoff GLP-1

    Novo Nordisk AS followed through on Monday in Delaware federal court on a plan it announced last week to sue telehealth company Hims & Hers Health Inc. over its marketing of what Novo Nordisk calls a knockoff version of its GLP-1 medications.

  • February 09, 2026

    Intellectual Property Group Of The Year: Susman Godfrey

    Susman Godfrey LLP attorneys in the past year achieved some of the most closely watched victories in copyright, privacy and life sciences, including a record-setting copyright class settlement over books Anthropic obtained to train its flagship artificial intelligence model, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.

  • February 09, 2026

    High Court Asked To Take Up Malpractice Case Against Akin

    A former Cornell University graduate student wants the U.S. Supreme Court to review the dismissal of his suit accusing Akin Gump Strauss Hauer & Feld LLP attorneys of manipulating patent litigation to steal his DNA sequencing intellectual property.

  • February 06, 2026

    Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit

    Takeda Pharmaceutical Co. and TWi Pharmaceuticals must face most of a proposed antitrust class action accusing them of delaying the release of the generic version of Takeda's heartburn medication Dexilant, causing Walgreens, Kroger and other retailers to pay more for the brand-name drug, a California federal judge ruled Friday.

  • February 06, 2026

    OpenAI Can Keep Atty Comms Secret After All, Judge Says

    A New York federal judge Friday set aside a magistrate judge's order requiring OpenAI's in-house attorneys to share their internal communications regarding deleted training datasets with authors suing over alleged copyright infringement, holding that the conclusions underlying that decision were "clearly erroneous or contrary to law."

  • February 06, 2026

    HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight

    U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo Nordisk A/S threatened litigation over what it called the telehealth company's "knockoff" version of its popular weight loss drug Wegovy.

  • February 06, 2026

    Squires Rules Inconsistent Claim Constructions Doom 3 IPRs

    U.S. Patent and Trademark Office Director John Squires has undone three decisions by the Patent Trial and Appeal Board instituting inter partes reviews, finding that the patent challengers made conflicting claim construction arguments in the reviews and in court.

  • February 06, 2026

    'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.

    D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt but also dodged opportunities to rule it out unequivocally.

  • February 06, 2026

    NJ Judge Tosses Pacira Investor Suit Over Patent Loss

    A New Jersey federal judge on Friday threw out an investor lawsuit against Pacira BioSciences Inc. after a court invalidated a patent for its key pain management drug, ruling that the pharmaceutical company was not required to disclose litigation setbacks it encountered before the final ruling.

  • February 06, 2026

    Tesla, X Accused Of Infringing Voice Assistance Tech Patent

    Tesla Inc., X Corp., and an Indian technology company were all hit with patent infringement lawsuits in Texas federal court over their technology that uses voice assistance.

  • February 06, 2026

    Skating, Twirling And Juggling IP Risk At The Winter Olympics

    Snowboarders, figure skaters, curlers and other competitive athletes have been training for years to be ready for the unexpected at the Winter Olympics, but intellectual property issues arising from taking part in the global sporting event are probably not high on their priority list.

  • February 06, 2026

    PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test

    The Patent Trial and Appeal Board has found that Geneoscopy had shown that all the claims it challenged in a patent on Exact Sciences' colon cancer test Cologuard are invalid as obvious, months after the PTAB invalidated claims in a similar patent.

  • February 06, 2026

    'Cardiac Pack' Wants NC Justices To Revive NIL Suit

    A group of former student-athletes from the early 1980s is urging North Carolina's highest court to revive their name, image and likeness lawsuit against the NCAA, arguing the organization's use of gameplay footage to advertise March Madness is a continuing harm.

  • February 06, 2026

    Tesla, Musk Must Face 'Blade Runner 2049' Copyright Suit

    A Los Angeles federal judge has declined Tesla and Elon Musk's request to throw out a copyright complaint accusing them of using imagery from the movie "Blade Runner 2049" to create a visual for a Tesla promotional event.

  • February 06, 2026

    Fed. Circ. Clears E-Tracking Patents In Apple PTAB Challenge

    The Federal Circuit on Friday rejected Apple's appeal of a Patent Trial and Appeal Board decision that upheld claims in an LBT patent for electronic location tracking.

  • February 06, 2026

    Squires Revives Dish Patent Over Pornhub RPI Error

    U.S. Patent and Trademark Office Director John Squires has vacated the Patent Trial and Appeal Board's invalidation of a Dish Technologies LLC streaming patent, saying it took too long to disclose a real party in interest.

  • February 06, 2026

    Jury Awards $8.4M In Oilfield Trade Secrets Theft Case

    A Texas federal jury has handed an oilfield services company $8.4 million in damages after finding a rival had willfully pilfered trade secrets related to nitrogen rejection unit technology when an employee left to start the rival firm.

  • February 06, 2026

    NH Supreme Court Upholds $23 Million Nokia Oral Deal

    The New Hampshire Supreme Court has affirmed a $23 million award a federal jury granted to Collision Communications against Nokia, representing the amount allegedly agreed upon in an over-the-phone deal made for patent licenses in 2017.

  • February 06, 2026

    Rupp Marine Didn't Infringe Fishing Line Patents, Judge Rules

    A Florida federal judge has ruled that marine supply store Rupp Marine Inc. did not infringe patents owned by Gem Products LLC for line management systems for fishing boats with outriggers.

  • February 06, 2026

    Fed. Circ. Backs Target's Alice Win Over Product Location IP

    The Federal Circuit on Friday refused to revive claims in a series of patents covering ways of finding products within a store, backing a lower court's finding that Target was able to show the claims were invalid under the U.S. Supreme Court's Alice standard.

  • February 06, 2026

    Insulet Gets $14.9M Fee Award For Trade Secret Trial Win

    A Massachusetts federal judge awarded Insulet Corp.'s attorneys almost $15 million for their $452 million jury trial victory in a trade secrets dispute that was later reduced to $59.4 million, but the fees Goodwin Procter LLP netted were significantly less than the nearly $25 million it requested.

  • February 06, 2026

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London saw a unit of Johnson & Johnson sue the U.S. government in a patent dispute, Southampton Football Club file a claim against Aviva Insurance, and an events business face a claim by Live Nation (Music) over potential licensing issues for Chelmsford City Live, a music festival that featured Justin Timberlake last year. Here, Law360 looks at these and other new claims in the U.K.

  • February 05, 2026

    Gilstrap Sends Tesla Patent Case From Texas To Calif.

    A Texas federal judge refused to change his mind — again — about transferring to California a patent infringement suit against Tesla related to technology used in self-driving cars, according to a Jan. 29 order unsealed Thursday.

Expert Analysis

  • Means-Plus-Function Terms In Software Claims May Be Risky

    Author Photo

    Though the Federal Circuit recently reversed a decision rejecting a set of means-plus-function software claims as lacking sufficient structure, practitioners who proceed under this holding may run into indefiniteness problems if they do not consider other Federal Circuit holdings related to the definiteness requirement, says Jeffrey Danley at Seed IP Law Group.

  • Training AI On Books: A Tale Of 2 Fair Use Rulings

    Author Photo

    Though two recent decisions from the Northern District of California concluded that training artificial intelligence with copyrighted books counts as fair use, certain meaningful differences in reasoning could affect pending and future cases, says Brett Carmody at Atheria Law.

  • Series

    Judging Figure Skating Makes Me A Better Lawyer

    Author Photo

    Judging figure skating competitions helps me hone the focus, decisiveness and ability to process complex real-time information I need in court, but more importantly, it makes me reengage with a community and my identity outside of law, which, paradoxically, always brings me back to work feeling restored, says Megan Raymond at Groombridge Wu.

  • Trending At The PTAB: Petitioners' Settled Expectations

    Author Photo

    Recent Patent Trial and Appeal Board decisions show that the U.S. Patent and Trademark Office's new "settled expectations" factor is no longer the exclusive domain of patent owners and can also provide petitioners with viable pathways to argue against discretionary denial, say attorneys at Finnegan.

  • Female Athletes' NIL Deal Challenge Could Be Game Changer

    Author Photo

    A challenge by eight female athletes to the NCAA’s $2.8 billion name, image and likeness settlement shows that women in sports are still fighting for their share — not just of money, but of respect, resources and representation, says Madilynne Lee at Anderson Kill.

  • What Ethics Rules Say On Atty Discipline For Online Speech

    Author Photo

    Though law firms are free to discipline employees for their online commentary about Charlie Kirk or other social media activity, saying crude or insensitive things on the internet generally doesn’t subject attorneys to professional discipline under the Model Rules of Professional Conduct, says Stacie H. Rosenzweig at Halling & Cayo.

  • Kimmel 2nd Circ. Victory Holds Novel Copyright Lessons

    Author Photo

    The Second Circuit's recent decision in Santos v. Kimmel, dismissing a copyright infringement claim against Kimmel for airing Cameo videos recorded by former U.S. Rep George Santos, examines the unusual situation of copyrighted works created at the request of the alleged infringer, say attorneys at Venable.

  • Junior Attys Must Beware Of 5 Common Legal Brief Mistakes

    Excerpt from Practical Guidance
    Author Photo

    Junior law firm associates must be careful to avoid five common pitfalls when drafting legal briefs — from including every possible argument to not developing a theme — to build the reputation of a sought-after litigator, says James Argionis at Cozen O'Connor.

  • Demystifying Generative AI For The Modern Juror

    Author Photo

    In cases alleging that the training of artificial intelligence tools violated copyright laws, successful outcomes may hinge in part on the litigator's ability to clearly present AI concepts through a persuasive narrative that connects with ordinary jurors, say Liz Babbitt at IMS Legal Strategies and Devon Madon at GlobalLogic.

  • Series

    Power To The Paralegals: How And Why Training Must Evolve

    Author Photo

    Empowering paralegals through new models of education that emphasize digital fluency, interdisciplinary collaboration and human-centered lawyering could help solve workforce challenges and the justice gap — if firms, educators and policymakers get on board, say Kristine Custodio Suero and Kelli Radnothy.

  • Series

    Playing Softball Makes Me A Better Lawyer

    Author Photo

    My time on the softball field has taught me lessons that also apply to success in legal work — on effective preparation, flexibility, communication and teamwork, says Sarah Abrams at Baleen Specialty.

  • And Now A Word From The Panel: Choosing MDL Venues

    Author Photo

    One of the most interesting yet least predictable facets of the Judicial Panel on Multidistrict Litigation's practice is venue — namely where the panel decides to place a new MDL proceeding — and its choices reflect the tension between neutrality and case-specific factors, says Alan Rothman at Sidley.

  • Fed. Circ. In August: A Framework For AIA Derivation Disputes

    Author Photo

    In Global Health Solutions v. Selner, the Federal Circuit established how to assess derivation challenges under the America Invents Act's first-to-file system, making it easier for petitioners to determine a challenge's odds of success, say attorneys at Knobbe Martens.

  • USPTO's Track One A Reliable Patent Pathway Amid Backlog

    Author Photo

    As the U.S. Patent and Trademark Office faces a backlog of unexamined utility, plant and reissue patent applications, patent applicants should consider utilizing the USPTO's Track One Program, which not only expedites the process but also increases the likelihood of working with more senior examiners, says Ryan Schermerhorn at Marshall Gerstein.

  • How New Rule On Illustrative Aids Is Faring In Federal Courts

    Author Photo

    In the 10 months since new standards were codified for illustrative aids in federal trials, courts have already begun to clarify the rule's application in different contexts and the rule's boundaries, say attorneys at Bernstein Litowitz.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.